Canadian case quandary: should IQ figure into transplant decisions?

Article Abstract:

The validity of using IQ measurements as a basis for denying medical care has come into question in the case of Kristina D'Andrea, a 3 1/2 year-old Canadian girl who suffers from mucopolysaccharidosis (MPS). D'Andrea was denied an experimental bone marrow transplant procedure because her IQ of 73 was below the 75 IQ minimum set by the doctors administering the program. D'Andrea's parents were upset at the doctors' decision. However, the doctors argue that MPS victims often suffer continued metal deterioration even after bone marrow transplants. Hence, the treatments should go to MPS patients that have a minimum level of mental capacity.

Analysis, Ethical aspects, Medical ethics, Discrimination in medical care, Medical care discrimination, Mucopolysaccharidosis, Mucopolysaccharidoses

---

Keeping the 'right' to die from becoming a mandate

Article Abstract:

Rita L. Marker, an ethics professor, was drawn into the 'right-to-die' debate by attending an euthanasia conference in France where a woman announced that the group had given her the courage to go home and kill herself. Marker has written a book about the subject and about Ann Humphry, the co-founder of the Hemlock Society. The book is called Deadly Compassion: The Death of Ann Humphry and the Truth About Euthanasia. Marker testifies in state legislatures, files briefs and appears on talk shows to fight euthanasia.

Criticism and interpretation, Personalities, Right to die, Deadly Compassion: The Death of Ann Humphry and the Truth About Euthanasia (Book), Marker, Rita L.

---

RU-486 gets FDA nod, but obstacles to wide use linger

Article Abstract:

The FDA's conditional approval in Sep 1996 of the abortion drug, RU-486, is not expected to result in a significant increase in the number of physicians who perform abortions, according to National Coalition of Abortion Providers executive director Ron Fitzsimmons. Fitzsimmons feels that the main obstacle to the drug's widespread use will come from practical considerations, involving a prolonged procedure and regimen.

Pharmaceutical Preparation Manufacturing, Pharmaceutical preparations, Oral Contraceptives, Usage, Forecasts and trends, Abortion, Abortifacients, Mifepristone, Fitzsimmons, Ron

Similar abstracts:

• Abstracts: The effect of race on access and outcome in transplantation. Abnormalities of lipoprotein metabolism in patients with the nephrotic syndrome
• Abstracts: Death and dignity: a case of individualized decision making. The Million dollar question
• Abstracts: A 35-year-old man with changed mental status and multiple intracerebral lesions. A 60-year-old man with multiple cerebral infarcts and cutaneous hemorrhagic lesions
• Abstracts: Pre-employment physicals and the ADA. Should you be an organ donor? Never assume with hydraulic fluids
• Abstracts: Some new lessons to consider about life - and death. It's time to interject reality into our expectations. Physician copes with fitness-crazed geriatric patients

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.